Metabolomics analysis of AsPC-1 PDAC cells treated with Porcupine inhibitor (LGK974)
Ontology highlight
ABSTRACT: WNT signaling promotes pancreatic ductal adenocarcinoma (PDAC) through diverse effects on proliferation, differentiation, survival, and stemness. A subset of PDAC with inactivating mutations in ring finger protein 43 (RNF43) have growth dependency on autocrine WNT ligand signaling, which renders them susceptible to porcupine inhibitors (PORCNi) that block WNT ligand acylation and secretion. For this study, non-targeted metabolomic analyses were performed to explore the therapeutic response of RNF43-mutant PDAC to the PORCNi LGK974. AsPC-1 (RNF43-mutant) PDAC cells were treated with 25 nM LGK974 to explore stable isotope-resolved metabolomics with uniform 1, D-glucose [U13-C6] labeling.
ORGANISM(S): Human Homo Sapiens
TISSUE(S): Cultured Cells
DISEASE(S): Cancer
SUBMITTER: David Dawson
PROVIDER: ST001902 | MetabolomicsWorkbench | Mon Jul 19 00:00:00 BST 2021
REPOSITORIES: MetabolomicsWorkbench
ACCESS DATA